Huberman Lab podcast out now is about PEPTIDES, which many associate with gray market biohacking. Yet, GLP1 analogues (Ozempic) were niche community use peptides until recently when they became 100B+ peptide industry. I cover the benefits & risks & explain basic peptide biology.

Thoughts about GLP1 medications

Officially 90 pounds lost! #Mounjaro #GLP1 SW 238, Current Weight 149!

#GLP1 receptor agonists (liraglutide and dulaglutide) reduce binge eating disorder frequency and comorbidities in addition to favorable psychiatric side effect profile, according to a recent meta-analysis of small pilot studies.

doi.org/10.1016/j.jcte…

Are you experiencing any of the most common side-effects while on GLP-1?

#Biocare #Biocare Nutrition #GLP1 #Semaglutide

🎉Our latest publication reveals that #GLP1 RAs ⬇️ #stroke risk by 16% in persons with #diabetes or #obesity !
📌This meta-analysis of 11 studies with 82,140 participants could be a game-changer for #stroke prevention🧠
🤔What about recurrent stroke?
journals.sagepub.com/doi/10.1177/17…

Poor adherence to GLP1‐RA & SGLT2‐I associated with worse outcomes

onlinelibrary.wiley.com/doi/pdfdirect/…

<Your monthly cost of GLP1 Medication>

New review highlights potential of GLP1-RAs in PCa management, suggesting their role in inhibiting cancer progression.More trials needed. #ProstateCancer MDPI Ryan Dobbs Wassim Abou-Kheir Elai Davicioni David I Lee, MD رعد الفاعوري Ra'ad Al-Faouri 𝐇𝐢𝐬𝐡𝐚𝐦 𝐁𝐚𝐡𝐦𝐚𝐝 Abdulrahman Alhajahjeh
mdpi.com/2072-6694/16/8…

The censorship of #GLP1 content, especially content like mine which is almost entirely focused on sharing news and clinical trial data, feels extremely discriminatory.

tinyurl.com/mrxehjfp

CC: Madison Muller

#elililly #novonordisk #ozempic #wegovy #zepbound #onthepen #mounjaro …

Albiglutide, a GLP1 agonist, demonstrated 22% cardiovascular event reduction📉in T2DM pts despite not generating much glucose lowering or weight loss.

These trial results suggest GLP1a has cardiovascular benefit ❤️even without improving risk factors.

pubmed.ncbi.nlm.nih.gov/30015066/

Bill Maher and I talk about the new scary findings n GLP1 drugs this week on Real Time.

Be sure to tune in!

#CGM and #GLP1 for #T2D

pubmed.ncbi.nlm.nih.gov/38666194/

If you are a clinician, you will love this guide ArodaMD ADA Professional Publications

GLP1 receptor agonists use and associations with outcomes in #HF and type 2 diabetes

🇸🇪HF Registry
👥8188 ⏰2017-2021 ▶️9% received a GLP-1 RA
👉GLP-1 RA use was
🔴not significantly associated with a composite of HF🏥/CV☠️regardless of EF,
🟢 was associated with ⬇️ risk of CV…

Food noise volume = 0%

#glp1 journey #foodnoise #glp1

Congress is definitely not ready for what could be an imminent explosion in Medicare spending, as GLP1 use scales up

I unfortunately couldn't attend the Stanford Diabetes Research symposium today, I'm glad Andrea d'Aquino got to share her work developing sustained delivery technologies for improving #GLP1 therapies!

23) Lets' go with the FLOW‼️

🔸🥇 #GLP1 Kidney Outcome Study

💉1mg semaglutide vs PBO

🔸n=3534

🌟 STOPPED early due to ⤵️ 🥇 outcome

⚠️ Full results to be presented ERA - European Renal Association May '24

👉🥇 ⤵️24%

⤵️Kidney and cardiovascular events
⤵️💔

🤢 Tolerability 'similar'…

New data 📈 from CGH showed:

#GLP1RAs 💊 linked to notably higher rate of retained gastric contents during upper #endoscopy

⬇️⬇️

healio.com/news/gastroent…